Zhongguo aizheng zazhi (Mar 2023)

Advances in basic research, clinical diagnosis and treatment of prostate cancer in 2022

  • PAN Jian, ZHU Yao, DAI Bo, YE Dingwei

DOI
https://doi.org/10.19401/j.cnki.1007-3639.2023.03.003
Journal volume & issue
Vol. 33, no. 3
pp. 210 – 217

Abstract

Read online

About 40%-70% of newly diagnosed prostate cancer patients in China are in the stage of metastatic disease, and the spatio-temporal heterogeneity of the occurrence and development of prostate cancer and the unique metastasis pattern make it difficult to analyze immune markers based on biopsy tissue. With the advancement of many basic and clinical studies, new advances have been made in the pathogenesis, diagnostic methods, perioperative management, radiotherapy techniques and systematic treatment of advanced diseases of prostate cancer. These results continuously enrich the means of diagnosis and treatment of prostate cancer patients and improve their prognosis. Here was a review of the major advances in prostate cancer research in 2022.

Keywords